scholarly journals Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

2015 ◽  
Vol 16 (8) ◽  
pp. 937-948 ◽  
Author(s):  
Josep Tabernero ◽  
Heinz-Josef Lenz ◽  
Salvatore Siena ◽  
Alberto Sobrero ◽  
Alfredo Falcone ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Exploratory Analysis ◽  
Clinical Activity ◽  
Circulating Dna ◽  
Protein Biomarkers ◽  
Correct Trial

scholarly journals Exploratory Analysis of a Prognosis Predictive Model for Metastatic Colorectal Cancer Treated with Chemotherapy

2014 ◽  
Vol 25 ◽  
pp. v73
Author(s):  
Mamoru Tanaka ◽  
Hozumi Kumagai ◽  
Junji Kishimoto ◽  
Satomi Mukaide ◽  
Hisanobu Oda ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Predictive Model ◽  
Exploratory Analysis

scholarly journals Phase 3 Correct Trial of Regorafenib in Metastatic Colorectal Cancer (MCRC): Overall Survival Update

2012 ◽  
Vol 23 ◽  
pp. ixe10 ◽  
Author(s):  
E.J.D. Van Cutsem ◽  
A. Grothey ◽  
A. Sobrero ◽  
S. Siena ◽  
A. Falcone ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Overall Survival ◽  
Metastatic Colorectal Cancer ◽  
Correct Trial ◽  
Phase 3

scholarly journals Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer

2019 ◽  
Vol 30 ◽  
pp. iv124-iv125 ◽  
Author(s):  
E. Van Cutsem ◽  
J. Machiels ◽  
M. Van den Eynde ◽  
H. Prenen ◽  
A. Hendlisz ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase 1 ◽  
Clinical Activity ◽  
Car T
Sign in / Sign up

Export Citation Format

Share Document